Cargando…
Recommended Immunological Assays to Screen for Ricin-Containing Samples
Ricin, a toxin from the plant Ricinus communis, is one of the most toxic biological agents known. Due to its availability, toxicity, ease of production and absence of curative treatments, ricin has been classified by the Centers for Disease Control and Prevention (CDC) as category B biological weapo...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4690108/ https://www.ncbi.nlm.nih.gov/pubmed/26703725 http://dx.doi.org/10.3390/toxins7124858 |
_version_ | 1782406956156190720 |
---|---|
author | Simon, Stéphanie Worbs, Sylvia Avondet, Marc-André Tracz, Dobryan M. Dano, Julie Schmidt, Lisa Volland, Hervé Dorner, Brigitte G. Corbett, Cindi R. |
author_facet | Simon, Stéphanie Worbs, Sylvia Avondet, Marc-André Tracz, Dobryan M. Dano, Julie Schmidt, Lisa Volland, Hervé Dorner, Brigitte G. Corbett, Cindi R. |
author_sort | Simon, Stéphanie |
collection | PubMed |
description | Ricin, a toxin from the plant Ricinus communis, is one of the most toxic biological agents known. Due to its availability, toxicity, ease of production and absence of curative treatments, ricin has been classified by the Centers for Disease Control and Prevention (CDC) as category B biological weapon and it is scheduled as a List 1 compound in the Chemical Weapons Convention. An international proficiency test (PT) was conducted to evaluate detection and quantification capabilities of 17 expert laboratories. In this exercise one goal was to analyse the laboratories’ capacity to detect and differentiate ricin and the less toxic, but highly homologuous protein R. communis agglutinin (RCA120). Six analytical strategies are presented in this paper based on immunological assays (four immunoenzymatic assays and two immunochromatographic tests). Using these immunological methods “dangerous” samples containing ricin and/or RCA120 were successfully identified. Based on different antibodies used the detection and quantification of ricin and RCA120 was successful. The ricin PT highlighted the performance of different immunological approaches that are exemplarily recommended for highly sensitive and precise quantification of ricin. |
format | Online Article Text |
id | pubmed-4690108 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-46901082015-12-30 Recommended Immunological Assays to Screen for Ricin-Containing Samples Simon, Stéphanie Worbs, Sylvia Avondet, Marc-André Tracz, Dobryan M. Dano, Julie Schmidt, Lisa Volland, Hervé Dorner, Brigitte G. Corbett, Cindi R. Toxins (Basel) Article Ricin, a toxin from the plant Ricinus communis, is one of the most toxic biological agents known. Due to its availability, toxicity, ease of production and absence of curative treatments, ricin has been classified by the Centers for Disease Control and Prevention (CDC) as category B biological weapon and it is scheduled as a List 1 compound in the Chemical Weapons Convention. An international proficiency test (PT) was conducted to evaluate detection and quantification capabilities of 17 expert laboratories. In this exercise one goal was to analyse the laboratories’ capacity to detect and differentiate ricin and the less toxic, but highly homologuous protein R. communis agglutinin (RCA120). Six analytical strategies are presented in this paper based on immunological assays (four immunoenzymatic assays and two immunochromatographic tests). Using these immunological methods “dangerous” samples containing ricin and/or RCA120 were successfully identified. Based on different antibodies used the detection and quantification of ricin and RCA120 was successful. The ricin PT highlighted the performance of different immunological approaches that are exemplarily recommended for highly sensitive and precise quantification of ricin. MDPI 2015-11-26 /pmc/articles/PMC4690108/ /pubmed/26703725 http://dx.doi.org/10.3390/toxins7124858 Text en © 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons by Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Simon, Stéphanie Worbs, Sylvia Avondet, Marc-André Tracz, Dobryan M. Dano, Julie Schmidt, Lisa Volland, Hervé Dorner, Brigitte G. Corbett, Cindi R. Recommended Immunological Assays to Screen for Ricin-Containing Samples |
title | Recommended Immunological Assays to Screen for Ricin-Containing Samples |
title_full | Recommended Immunological Assays to Screen for Ricin-Containing Samples |
title_fullStr | Recommended Immunological Assays to Screen for Ricin-Containing Samples |
title_full_unstemmed | Recommended Immunological Assays to Screen for Ricin-Containing Samples |
title_short | Recommended Immunological Assays to Screen for Ricin-Containing Samples |
title_sort | recommended immunological assays to screen for ricin-containing samples |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4690108/ https://www.ncbi.nlm.nih.gov/pubmed/26703725 http://dx.doi.org/10.3390/toxins7124858 |
work_keys_str_mv | AT simonstephanie recommendedimmunologicalassaystoscreenforricincontainingsamples AT worbssylvia recommendedimmunologicalassaystoscreenforricincontainingsamples AT avondetmarcandre recommendedimmunologicalassaystoscreenforricincontainingsamples AT traczdobryanm recommendedimmunologicalassaystoscreenforricincontainingsamples AT danojulie recommendedimmunologicalassaystoscreenforricincontainingsamples AT schmidtlisa recommendedimmunologicalassaystoscreenforricincontainingsamples AT vollandherve recommendedimmunologicalassaystoscreenforricincontainingsamples AT dornerbrigitteg recommendedimmunologicalassaystoscreenforricincontainingsamples AT corbettcindir recommendedimmunologicalassaystoscreenforricincontainingsamples |